Literature DB >> 21878799

Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes.

Allen Chiang1, Richard S Kaiser, Robert L Avery, Pravin U Dugel, Dean Eliott, Sumit P Shah, Jeffrey Heier, Jay Duker, Allen Y Hu, Steven D Schwartz, Ingrid U Scott, John S Pollack, Lisa J Faia, George A Williams.   

Abstract

PURPOSE: To assess whether performing an air or gas exchange at the conclusion of a microincision vitrectomy procedure is beneficial regarding the rate of endophthalmitis.
METHODS: This was a collaborative, multicenter, retrospective chart review of 2,336 eyes that underwent microincision sutureless vitrectomy (23 or 25 gauge) with either SF6 or C3F8 gas endotamponade for macular hole between January 2008 and December 2009. For all eyes, the search methodology was structured to identify the main outcome measure, which was the occurrence of acute postoperative endophthalmitis (<6 weeks after pars plana vitrectomy).
RESULTS: Of the cumulative 2,336 consecutive cases over a 2-year period, only 1 (0.04%) had postoperative endophthalmitis. All eyes had near-complete gas-fluid exchange at the end of surgery; C3F8 was the most common endotamponade agent. The majority of cases were performed with 23-gauge vitrectomy. No other complications were noted.
CONCLUSION: Endophthalmitis was a rare occurrence in this large series of gas-filled eyes after macular hole surgery (0.04%). Gas endotamponade after microincision sutureless vitrectomy may be beneficial in reducing the risk of postoperative endophthalmitis; however, additional studies are necessary to make a definitive recommendation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878799     DOI: 10.1097/IAE.0b013e3182209290

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.

Authors:  Mikel Mikhail; Andre Ali-Ridha; Sarah Chorfi; Michael A Kapusta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-02       Impact factor: 3.117

2.  Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes.

Authors:  Fadi Maalouf; Marwan Abdulaal; Rola N Hamam
Journal:  Int J Inflam       Date:  2012-02-22

Review 3.  Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes.

Authors:  Vivek Pravin Dave; Avinash Pathengay; Stephen G Schwartz; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2014-10-31

Review 4.  The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International Perspective.

Authors:  Andrzej Grzybowski; Magdalena Turczynowska; Stephen G Schwartz; Nidhi Relhan; Harry W Flynn
Journal:  Ophthalmol Ther       Date:  2020-07-01

5.  Endophthalmitis Post Pars Plana Vitrectomy Surgery: Incidence, Organisms' Profile, and Management Outcome in a Tertiary Eye Hospital in Saudi Arabia.

Authors:  Bedoor AlBloushi; Marco Mura; Rajiv Khandekar; Saleh AlMesfer; Abdulmalik AlYahya; Khaled Alabduljabbar; Shaimaa AlRefaie; Valmore A Semidey
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

6.  Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital.

Authors:  Muna Bhende; Rajiv Raman; Mukesh Jain; Pratik K Shah; Tarun Sharma; Lingam Gopal; Pramod S Bhende; Sangeetha Srinivasan; Malathi Jambulingam
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

7.  Is it necessary to use tobramycin-dexamethasone eye ointment prophylactically in eyes at the end of intraocular surgery?

Authors:  Wei Zhang; Han Han; Kang Feng; Xiaohong Wang; Mei Du; Xiangda Meng; Yuanyuan Liu; Bo Huang; Rodrigo Brant; Hua Yan
Journal:  BMC Ophthalmol       Date:  2020-05-27       Impact factor: 2.209

Review 8.  Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.

Authors:  Yan Nuzbrokh; Alexis S Kassotis; Sara D Ragi; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmol Ther       Date:  2020-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.